nih-gov/www.ncbi.nlm.nih.gov/books/n/ukeme0804/index.html

478 lines
No EOL
68 KiB
HTML
Raw Blame History

This file contains ambiguous Unicode characters

This file contains Unicode characters that might be confused with other characters. If you think that this is intentional, you can safely ignore this warning. Use the Escape button to reveal them.

<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<!-- AppResources meta begin -->
<meta name="paf-app-resources" content="" />
<script type="text/javascript">var ncbi_startTime = new Date();</script>
<!-- AppResources meta end -->
<!-- TemplateResources meta begin -->
<meta name="paf_template" content="" />
<!-- TemplateResources meta end -->
<!-- Logger begin -->
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-toc" /><meta name="ncbi_acc" content="NBK568919" /><meta name="ncbi_domain" content="ukeme0804" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK568919/" /><meta name="ncbi_pagename" content="Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="toc" /><meta name="ncbi_app" content="bookshelf" />
<!-- Logger end -->
<title>Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study - NCBI Bookshelf</title>
<!-- AppResources external_resources begin -->
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
<!-- AppResources external_resources end -->
<!-- Page meta begin -->
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE,NOIMAGEINDEX" /><meta name="author" content="Sven Plein, Bara Erhayiem, Graham Fent, Jacqueline Andrews, John Greenwood, Paul Baxter, Elizabeth M Hensor, Sue Pavitt, Maya H Buch" /><meta name="citation_title" content="Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study" /><meta name="citation_publisher" content="NIHR Journals Library" /><meta name="citation_date" content="2021/03" /><meta name="citation_author" content="Sven Plein" /><meta name="citation_author" content="Bara Erhayiem" /><meta name="citation_author" content="Graham Fent" /><meta name="citation_author" content="Jacqueline Andrews" /><meta name="citation_author" content="John Greenwood" /><meta name="citation_author" content="Paul Baxter" /><meta name="citation_author" content="Elizabeth M Hensor" /><meta name="citation_author" content="Sue Pavitt" /><meta name="citation_author" content="Maya H Buch" /><meta name="citation_pmid" content="33780206" /><meta name="citation_doi" content="10.3310/eme08040" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK568919/" /><meta name="citation_keywords" content="RHEUMATOID ARTHRITIS" /><meta name="citation_keywords" content="CARDIOVASCULAR DISEASE" /><meta name="citation_keywords" content="MRI" /><meta name="citation_keywords" content="ANTI-TNF" /><meta name="citation_keywords" content="METHOTREXATE" /><meta name="citation_keywords" content="AORTIC STIFFNESS" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="NIHR Journals Library" /><meta name="DC.Contributor" content="Sven Plein" /><meta name="DC.Contributor" content="Bara Erhayiem" /><meta name="DC.Contributor" content="Graham Fent" /><meta name="DC.Contributor" content="Jacqueline Andrews" /><meta name="DC.Contributor" content="John Greenwood" /><meta name="DC.Contributor" content="Paul Baxter" /><meta name="DC.Contributor" content="Elizabeth M Hensor" /><meta name="DC.Contributor" content="Sue Pavitt" /><meta name="DC.Contributor" content="Maya H Buch" /><meta name="DC.Date" content="2021/03" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK568919/" /><meta name="description" content="This study provides evidence of the changes in aortic distensibility in early rheumatoid arthritis and shows improvement of these at 1 year with DMARD therapy" /><meta name="og:title" content="Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study" /><meta name="og:type" content="book" /><meta name="og:description" content="This study provides evidence of the changes in aortic distensibility in early rheumatoid arthritis and shows improvement of these at 1 year with DMARD therapy" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK568919/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-ukeme0804-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/ukeme0804/toc/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK568919/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} </style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script><meta name="book-collection" content="ukemecollect" />
<!-- Page meta end -->
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B75CF7D7A1AE100000000008E006D.m_13" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/4207974/4206132/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
<body class="book-toc">
<div class="grid">
<div class="col twelve_col nomargin shadow">
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
<div class="sysmessages">
<noscript>
<p class="nojs">
<strong>Warning:</strong>
The NCBI web site requires JavaScript to function.
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
</p>
</noscript>
</div>
<!--/.sysmessage-->
<div class="wrap">
<div class="page">
<div class="top">
<div id="universal_header">
<section class="usa-banner">
<div class="usa-accordion">
<header class="usa-banner-header">
<div class="usa-grid usa-banner-inner">
<img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
<p>An official website of the United States government</p>
<button class="non-usa-accordion-button usa-banner-button" aria-expanded="false" aria-controls="gov-banner-top" type="button">
<span class="usa-banner-button-text">Here's how you know</span>
</button>
</div>
</header>
<div class="usa-banner-content usa-grid usa-accordion-content" id="gov-banner-top" aria-hidden="true">
<div class="usa-banner-guidance-gov usa-width-one-half">
<img class="usa-banner-icon usa-media_block-img" src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg" alt="Dot gov" />
<div class="usa-media_block-body">
<p>
<strong>The .gov means it's official.</strong>
<br />
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you're on a federal
government site.
</p>
</div>
</div>
<div class="usa-banner-guidance-ssl usa-width-one-half">
<img class="usa-banner-icon usa-media_block-img" src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg" alt="Https" />
<div class="usa-media_block-body">
<p>
<strong>The site is secure.</strong>
<br />
The <strong>https://</strong> ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
</p>
</div>
</div>
</div>
</div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">
<div class="usa-grid">
<div class="usa-width-one-whole">
<div class="ncbi-header__logo">
<a href="/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
<img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
</a>
</div>
<div class="ncbi-header__account">
<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
<button id="account_info" class="header-button" style="display:none" aria-controls="account_popup" type="button">
<span class="fa fa-user" aria-hidden="true">
<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" width="20px" height="20px">
<g style="fill: #fff">
<ellipse cx="12" cy="8" rx="5" ry="6"></ellipse>
<path d="M21.8,19.1c-0.9-1.8-2.6-3.3-4.8-4.2c-0.6-0.2-1.3-0.2-1.8,0.1c-1,0.6-2,0.9-3.2,0.9s-2.2-0.3-3.2-0.9 C8.3,14.8,7.6,14.7,7,15c-2.2,0.9-3.9,2.4-4.8,4.2C1.5,20.5,2.6,22,4.1,22h15.8C21.4,22,22.5,20.5,21.8,19.1z"></path>
</g>
</svg>
</span>
<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
<span class="sr-only">Show account info</span>
</button>
</div>
<div class="ncbi-popup-anchor">
<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
<div class="ncbi-popup-head">
<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu" type="button">
<span class="fa fa-times">
<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" height="24px">
<path d="M38 12.83l-2.83-2.83-11.17 11.17-11.17-11.17-2.83 2.83 11.17 11.17-11.17 11.17 2.83 2.83 11.17-11.17 11.17 11.17 2.83-2.83-11.17-11.17z"></path>
</svg>
</span>
<span class="usa-sr-only">Close</span></button>
<h4>Account</h4>
</div>
<div class="account-user-info">
Logged in as:<br />
<b><span class="username" id="uname_long">username</span></b>
</div>
<div class="account-links">
<ul class="usa-unstyled-list">
<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
</ul>
</div>
</div>
</div>
</div>
</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
<div class="ncbi-alerts-placeholder"></div>
</section>
</div>
<div class="header">
<div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
<div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" data-ac_dict="bookshelf-search">Books</option><option value="pubmed">PubMed</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore" class="last">Nucleotide</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
<a href="/books/browse/">Browse Titles</a>
</li><li>
<a href="/books/advanced/">Advanced</a>
</li><li class="help">
<a href="/books/NBK3833/">Help</a>
</li><li class="disclaimer">
<a target="_blank" data-ga-category="literature_resources" data-ga-action="link_click" data-ga-label="disclaimer_link" href="https://www.ncbi.nlm.nih.gov/books/about/disclaimer/">Disclaimer</a>
</li></ul></div>
</div>
<!--<component id="Page" label="headcontent"/>-->
</div>
<div class="content">
<!-- site messages -->
<!-- Custom content 1 -->
<div class="col1">
</div>
<div class="container">
<div id="maincontent" class="content eight_col col">
<!-- Custom content in the left column above book nav -->
<div class="col2">
</div>
<!-- Book content -->
<!-- Custom content between navigation and content -->
<div class="col3">
</div>
<div class="source">
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p></div><div class="pagination bk_noprnt"><span class="inactive page_link prev">&lt; Prev</span><a class="active page_link next" href="/books/n/ukeme0804/abs2/" title="Next page in this title">Next &gt;</a></div></div></div>
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/Book"><div class="meta-content fm-sec"><div class="iconblock whole_rhythm clearfix no_top_margin"><a href="http://www.journalslibrary.nihr.ac.uk/eme" title="NIHR Journals Library" class="img_link icnblk_img" ref="pagearea=logo&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-ukeme0804-lrg.png" alt="Cover of Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study" /></a><div class="icnblk_cntnt"><h1 id="_NBK568919_"><span itemprop="name">Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study</span></h1><p><i>Efficacy and Mechanism Evaluation, No. 8.4</i></p><p class="contrib-group"><span itemprop="author">Sven Plein</span>, <span itemprop="author">Bara Erhayiem</span>, <span itemprop="author">Graham Fent</span>, <span itemprop="author">Jacqueline Andrews</span>, <span itemprop="author">John Greenwood</span>, <span itemprop="author">Paul Baxter</span>, <span itemprop="author">Elizabeth M Hensor</span>, <span itemprop="author">Sue Pavitt</span>, and <span itemprop="author">Maya H Buch</span>.</p><a data-jig="ncbitoggler" href="#__NBK568919_ai__" style="border:0;text-decoration:none">Author Information and Affiliations</a><div style="display:none" class="ui-widget" id="__NBK568919_ai__"><p class="contrib-group"><h4>Authors</h4><span itemprop="author">Sven Plein</span>,<sup>1</sup> <span itemprop="author">Bara Erhayiem</span>,<sup>1</sup> <span itemprop="author">Graham Fent</span>,<sup>1</sup> <span itemprop="author">Jacqueline Andrews</span>,<sup>2</sup> <span itemprop="author">John Greenwood</span>,<sup>1</sup> <span itemprop="author">Paul Baxter</span>,<sup>3</sup> <span itemprop="author">Elizabeth M Hensor</span>,<sup>2,4</sup> <span itemprop="author">Sue Pavitt</span>,<sup>5</sup> and <span itemprop="author">Maya H Buch</span><sup>2,6,7</sup><sup>,*</sup>.</p><h4>Affiliations</h4><div class="affiliation"><sup>1</sup> Department of Biomedical Imaging Science, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK</div><div class="affiliation"><sup>2</sup> Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK</div><div class="affiliation"><sup>3</sup> Department of Specialist Science Education, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK</div><div class="affiliation"><sup>4</sup> National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK</div><div class="affiliation"><sup>5</sup> Dental Translational Clinical Research Unit, School of Dentistry, University of Leeds, Leeds, UK</div><div class="affiliation"><sup>6</sup> Centre for Musculoskeletal Research, Division of Musculoskeletal &#x00026; Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine &#x00026; Health, University of Manchester, Manchester, UK</div><div class="affiliation"><sup>7</sup> NIHR Manchester Biomedical Research Centre, Manchester, UK</div><div class="affiliation"><sup>*</sup> Corresponding author<span class="before-email-separator">; </span><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.retsehcnam@hcub.ayam" class="oemail">ku.ca.retsehcnam@hcub.ayam</a></div></div><div class="half_rhythm">Southampton (UK): <a href="http://www.journalslibrary.nihr.ac.uk/eme" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher"><span itemprop="publisher">NIHR Journals Library</span></a>; <span itemprop="datePublished">2021 Mar</span>.</div><div class="half_rhythm"><ul class="inline_list"><li><span class="label"><a data-jig="ncbidialog" href="#_ncbi_dlg_cpyrght_NBK568919" data-jigconfig="modal:true">Copyright and
Permissions</a></span></li></ul></div><div id="_ncbi_dlg_cpyrght_NBK568919" style="display:none" title="Copyright and&#10; Permissions"><div><div>Copyright &#x000a9; Queen&#x02019;s Printer and Controller of HMSO 2021. This work was produced by Plein et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.</div><div class="half_rhythm"></div></div></div><div class="bk_noprnt"><form method="get" action="/books/n/ukeme0804/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search this book" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search this book" submit="false" style="padding: 0.1em 0.4em;" /></div></form></div></div></div></div><div class="body-content whole_rhythm" itemprop="text"><div itemprop="description"><h2>Headline</h2><p>This study provides evidence of the changes in aortic distensibility in early rheumatoid arthritis and shows improvement of these at 1 year with DMARD therapy</p></div><div itemprop="description"><h2>Abstract</h2><div id="abs1-1"><h4 class="inline">Background:</h4><p>The VEDERA (Very Early vs. Delayed Etanercept in Rheumatoid Arthritis) randomised controlled trial compared the effect of conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) therapy with biologic DMARD (bDMARD) therapy using the tumour necrosis factor inhibitor etanercept in treatment-naive, early rheumatoid arthritis patients. The CADERA (Coronary Artery Disease Evaluation in Rheumatoid Arthritis) trial was a bolt-on study in which VEDERA patients underwent cardiovascular magnetic resonance imaging to detect preclinical cardiovascular disease at baseline and following treatment.</p></div><div id="abs1-2"><h4 class="inline">Objectives:</h4><p>To evaluate whether or not patients with treatment-naive early rheumatoid arthritis have evidence of cardiovascular disease compared with matched control subjects; whether or not this is modifiable with DMARD therapy; and whether or not bDMARDs confer advantages over csDMARDs.</p></div><div id="abs1-3"><h4 class="inline">Design:</h4><p>The VEDERA patients underwent cardiovascular magnetic resonance imaging at baseline and at 1 and 2 years after treatment.</p></div><div id="abs1-4"><h4 class="inline">Setting:</h4><p>The setting was a tertiary centre rheumatology outpatient clinic and specialist cardiovascular magnetic resonance imaging unit.</p></div><div id="abs1-5"><h4 class="inline">Participants:</h4><p>Eighty-one patients completed all assessments at baseline, 71 completed all assessments at 1 year and 56 completed all assessments at 2 years. Patients had no history of cardiovascular disease, had had rheumatoid arthritis symptoms for &#x02264;&#x02009;1 year, were DMARD treatment-naive and had a minimum Disease Activity Score-28 of 3.2. Thirty control subjects without cardiovascular disease were approximately individually matched by age and sex to the first 30 CADERA patients. Patients with a Disease Activity Score-28 of &#x02265;&#x02009;2.6 at 48 weeks were considered non-responders.</p></div><div id="abs1-6"><h4 class="inline">Interventions:</h4><p>In the VEDERA trial patients were randomised to group 1, immediate etanercept and methotrexate, or group 2, methotrexate&#x02009;&#x000b1;&#x02009;additional csDMARD therapy in a treat-to-target approach, with a switch to delayed etanercept and methotrexate in the event of failure to achieve clinical remission at 6 months.</p></div><div id="abs1-7"><h4 class="inline">Main outcome measures:</h4><p>The primary outcome measure was difference in baseline aortic distensibility between control subjects and the early rheumatoid arthritis group and the baseline to year 1 change in aortic distensibility in the early rheumatoid arthritis group. Secondary outcome measures were myocardial perfusion reserve, left ventricular strain and twist, left ventricular ejection fraction and left ventricular mass.</p></div><div id="abs1-8"><h4 class="inline">Results:</h4><p>Baseline aortic distensibility [geometric mean (95% confidence interval)] was significantly reduced in patients (<i>n</i>&#x02009;=&#x02009;81) compared with control subjects (<i>n</i>&#x02009;=&#x02009;30) [3.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg (2.7&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg to 3.3&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg) vs. 4.4&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg (3.7&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg to 5.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg), respectively; <i>p</i>&#x02009;&#x0003c;&#x02009;0.001]. Aortic distensibility [geometric mean (95% confidence interval)] improved significantly from baseline to year 1 across the whole patient cohort (<i>n</i>&#x02009;=&#x02009;81, with imputation for missing values) [3.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg (2.7&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg to 3.4&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg) vs. 3.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg (3.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg to 4.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg), respectively; <i>p</i>&#x02009;&#x0003c;&#x02009;0.001]. No significant difference in aortic distensibility improvement between baseline and year 1 was seen in the following comparisons (geometric means): group 1 (<i>n</i>&#x02009;=&#x02009;40 at baseline) versus group 2 (<i>n</i>&#x02009;=&#x02009;41 at baseline): 3.8&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg versus 3.4&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg, <i>p</i>&#x02009;=&#x02009;0.49; combined groups 1 and 2 non-responders (<i>n</i>&#x02009;=&#x02009;38) versus combined groups 1 and 2 responders (<i>n</i>&#x02009;=&#x02009;43): 3.5&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg versus 3.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg, <i>p</i>&#x02009;=&#x02009;0.87; group 1 non-responders (<i>n</i>&#x02009;=&#x02009;17) versus group 1 responders (<i>n</i>&#x02009;=&#x02009;23): 3.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg versus 3.9&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg, <i>p</i>&#x02009;=&#x02009;0.73. There was a trend towards a 10&#x02013;30% difference in aortic distensibility between (group 1) responders who received first-line etanercept (<i>n</i>&#x02009;=&#x02009;23) and (group 2) responders who never received etanercept (<i>n</i>&#x02009;=&#x02009;13): 3.9&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg versus 2.8&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;3</sup>/mmHg, <i>p</i>&#x02009;=&#x02009;0.19; ratio 0.7 (95% confidence interval 0.4 to 1.2), <i>p</i>&#x02009;=&#x02009;0.19; ratio adjusted for baseline aortic distensibility 0.8 (95% confidence interval 0.5 to 1.2), <i>p</i>&#x02009;=&#x02009;0.29; ratio fully adjusted for baseline characteristics 0.9 (95% confidence interval 0.6 to 1.4), <i>p</i>&#x02009;=&#x02009;0.56.</p></div><div id="abs1-9"><h4 class="inline">Conclusions:</h4><p>The CADERA establishes evidence of the vascular changes in early rheumatoid arthritis compared with controls and shows improvement of vascular changes with rheumatoid arthritis DMARD therapy. Response to rheumatoid arthritis therapy does not add further to modification of cardiovascular disease but, within the response to either strategy, etanercept/methotrexate may confer greater benefits over standard methotrexate/csDMARD therapy.</p></div><div id="abs1-10"><h4 class="inline">Trial registration:</h4><p>Current Controlled Trials ISRCTN89222125 and ClinicalTrials.gov <a href="https://clinicaltrials.gov/show/NCT01295151" title="Study NCT01295151" ref="pagearea=abstract&amp;targetsite=external&amp;targetcat=link&amp;targettype=clinical-trial">NCT01295151</a>.</p></div><div id="abs1-11"><h4 class="inline">Funding:</h4><p>This project was funded by the Efficacy and Mechanism Evaluation programme, a Medical Research Council and National Institute for Health Research (NIHR) partnership, and will be published in full in <i>Efficacy and Mechanism Evaluation</i>; Vol. 8, No. 4. See the NIHR Journals Library website for further project information. Pfizer Inc. (New York, NY, USA) supported the parent study, VEDERA, through an investigator-sponsored research grant reference WS1092499.</p></div></div><div><h2>Contents</h2><div class="bktoc_all_cntnr top align_right" style="display:none"><ul class="inline_list_right"><li><a class="bktoc_all_exp" href="#">Expand All</a></li><li style="margin-left:.8em"><a class="bktoc_all_clps" href="#">Collapse All</a></li></ul></div><ul id="toc_tllNBK568919_toc_abs2" class="simple-list toc toc-toggle"><li class="half_rhythm" id="toc_itm_NBK568919_toc_abs2"><a class="toc-item" href="/books/n/ukeme0804/abs2/">Plain English summary</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_abs3"><a class="toc-item" href="/books/n/ukeme0804/abs3/">Scientific summary</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s1"><a class="toc-item" href="/books/n/ukeme0804/s1/">Chapter 1. Introduction</a><ul id="toc_lst_NBK568919_toc_s1" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK568919_toc_s1-1"><a class="toc-item" href="/books/n/ukeme0804/s1/#s1-1">Background</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s1-2"><a class="toc-item" href="/books/n/ukeme0804/s1/#s1-2">Rheumatoid arthritis time course and excess cardiovascular disease</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s1-3"><a class="toc-item" href="/books/n/ukeme0804/s1/#s1-3">Therapeutic strategies in new-onset early rheumatoid arthritis</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s1-4"><a class="toc-item" href="/books/n/ukeme0804/s1/#s1-4">Effect of rheumatoid arthritis disease-modifying anti-rheumatic drug therapy on cardiovascular disease outcomes</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s1-5"><a class="toc-item" href="/books/n/ukeme0804/s1/#s1-5">Cardiovascular magnetic resonance studies in rheumatoid arthritis</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s1-6"><a class="toc-item" href="/books/n/ukeme0804/s1/#s1-6">The VEDERA trial</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s1-7"><a class="toc-item" href="/books/n/ukeme0804/s1/#s1-7">The CADERA study rationale</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s1-8"><a class="toc-item" href="/books/n/ukeme0804/s1/#s1-8">The clinical unmet need</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s2"><a class="toc-item" href="/books/n/ukeme0804/s2/">Chapter 2. Clinical trial methods</a><ul id="toc_lst_NBK568919_toc_s2" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK568919_toc_s2-1"><a class="toc-item" href="/books/n/ukeme0804/s2/#s2-1">Objectives</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s2-2"><a class="toc-item" href="/books/n/ukeme0804/s2/#s2-2">Design</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s2-3"><a class="toc-item" href="/books/n/ukeme0804/s2/#s2-3">Patient and public involvement</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s2-4"><a class="toc-item" href="/books/n/ukeme0804/s2/#s2-4">Participants</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s2-5"><a class="toc-item" href="/books/n/ukeme0804/s2/#s2-5">Interventions</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s2-6"><a class="toc-item" href="/books/n/ukeme0804/s2/#s2-6">Study procedures</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s2-7"><a class="toc-item" href="/books/n/ukeme0804/s2/#s2-7">Outcome measures</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s2-8"><a class="toc-item" href="/books/n/ukeme0804/s2/#s2-8">Patient withdrawal</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s2-9"><a class="toc-item" href="/books/n/ukeme0804/s2/#s2-9">Sample size and power calculation</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s2-10"><a class="toc-item" href="/books/n/ukeme0804/s2/#s2-10">Blinding</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s2-11"><a class="toc-item" href="/books/n/ukeme0804/s2/#s2-11">Analysis</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s3"><a class="toc-item" href="/books/n/ukeme0804/s3/">Chapter 3. Clinical trial results</a><ul id="toc_lst_NBK568919_toc_s3" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK568919_toc_s3-1"><a class="toc-item" href="/books/n/ukeme0804/s3/#s3-1">Patient recruitment</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s3-2"><a class="toc-item" href="/books/n/ukeme0804/s3/#s3-2">Primary objectives</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s3-3"><a class="toc-item" href="/books/n/ukeme0804/s3/#s3-3">Secondary objectives</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s4"><a class="toc-item" href="/books/n/ukeme0804/s4/">Chapter 4. Discussion</a><ul id="toc_lst_NBK568919_toc_s4" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK568919_toc_s4-1"><a class="toc-item" href="/books/n/ukeme0804/s4/#s4-1">Baseline assessment</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s4-2"><a class="toc-item" href="/books/n/ukeme0804/s4/#s4-2">Treatment effects</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s4-3"><a class="toc-item" href="/books/n/ukeme0804/s4/#s4-3">Study limitations</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s4-4"><a class="toc-item" href="/books/n/ukeme0804/s4/#s4-4">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_s4-5"><a class="toc-item" href="/books/n/ukeme0804/s4/#s4-5">Recommendations</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_ack1"><a class="toc-item" href="/books/n/ukeme0804/ack1/">Acknowledgements</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_ref1"><a class="toc-item" href="/books/n/ukeme0804/ref1/">References</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_app1"><a class="toc-item" href="/books/n/ukeme0804/app1/">Appendix 1. The VEDERA trial design</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_app2"><a class="toc-item" href="/books/n/ukeme0804/app2/">Appendix 2. The CADERA study design</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_app3"><a class="toc-item" href="/books/n/ukeme0804/app3/">Appendix 3. Additional tables</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_app4"><a class="toc-item" href="/books/n/ukeme0804/app4/">Appendix 4. Protocol amendments July 2018</a></li><li class="half_rhythm" id="toc_itm_NBK568919_toc_g1"><a class="toc-item" href="/books/n/ukeme0804/g1/">List of abbreviations</a></li></ul><div class="bktoc_all_cntnr align_right" style="display:none"><ul class="inline_list_right"><li><a class="bktoc_all_exp" href="#">Expand All</a></li><li style="margin-left:.8em"><a class="bktoc_all_clps" href="#">Collapse All</a></li></ul></div></div><div class="pmc_boxed-text-box fm-sec whole_rhythm"><h3>About the Series</h3><div class="half_rhythm"><div>Efficacy and Mechanism Evaluation</div></div><div class="half_rhythm"><div>ISSN (Print): 2050-4365</div><div>ISSN (Electronic): 2050-4373</div></div></div><div><p>Declared competing interests of authors: Maya H Buch reports grants and personal fees from Pfizer Inc. (New York, NY, USA), grants from Roche-Chugai (Tokyo, Japan) and UCB (Brussels, Belgium) and personal fees from AstraZeneca plc (Cambridge, UK), Bristol-Myers Squibb Co. (New York, NY, USA), Mitsubishi Tanabe Pharma Corp. (Osaka, Japan), Sandoz (Holzkirchen, Germany), R-Pharm (Moscow, Russia), Sanofi (Paris, France), Merck Serono (Darmstadt, Germany) and Roche-Chugai outside the submitted work. Elizabeth M Hensor reports grants from the National Institute for Health Research (NIHR) and grants from Versus Arthritis [formerly Arthritis Research UK (London, UK)] outside the submitted work. Sue Pavitt is NIHR Clinical Research Network (CRN) National Specialty Lead for Oral and Dental Health. She also reports non-financial support from NIHR CTU Standing Advisory Committee and from NIHR EME outside the submitted work. In addition, the NIHR CRN Specialty Leadership role attracts one programmed activity of funding outside the submitted work. Graham Fent reports support from Novartis International AG (Basel, Switzerland) outside the submitted work.</p></div><div><div id="n1-1"><h2>Article history</h2><p>The research reported in this issue of the journal was funded by the EME programme as project number 11/117/27. The contractual start date was in April 2013. The final report began editorial review in November 2018 and was accepted for publication in August 2019. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The EME editors and production house have tried to ensure the accuracy of the authors&#x02019; report and would like to thank the reviewers for their constructive comments on the final report document. However, they do not accept liability for damages or losses arising from material published in this report.</p></div></div><p class="small">Last reviewed: November 2018; Accepted: August 2019.</p></div></div>
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © Queens Printer and Controller of HMSO 2021. This work was produced by Plein <i>et al.</i> under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.</div><div class="small"><span class="label">Bookshelf ID: NBK568919</span><span class="label">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33780206" title="PubMed record of this title" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">33780206</a></span>DOI: <a href="http://dx.crossref.org/10.3310/eme08040" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10.3310/eme08040</a></div><div style="margin-top:2em" class="bk_noprnt"><div class="pagination bk_noprnt"><span class="inactive page_link prev">&lt; Prev</span><a class="active page_link next" href="/books/n/ukeme0804/abs2/" title="Next page in this title">Next &gt;</a></div></div></div></div>
</div>
<!-- Custom content below content -->
<div class="col4">
</div>
<!-- Book content -->
<!-- Custom contetnt below bottom nav -->
<div class="col5">
</div>
</div>
<div id="rightcolumn" class="four_col col last">
<!-- Custom content above discovery portlets -->
<div class="col6">
<div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK568919&amp;db=books">Share</a></div>
</div>
<div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK568919/?report=reader">PubReader</a></li><li><a href="/books/NBK568919/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK568919" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK568919" style="display:none" title="Cite this Page"><div class="bk_tt">Plein S, Erhayiem B, Fent G, et al. Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study. Southampton (UK): NIHR Journals Library; 2021 Mar. (Efficacy and Mechanism Evaluation, No. 8.4.)<span class="bk_cite_avail"></span> doi: 10.3310/eme08040</div></div></li><li><a href="/books/n/ukeme0804/pdf/">PDF version of this title</a> (890K)</li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Other titles in this collection</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/ukemecollect/">Efficacy and Mechanism Evaluation</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=nlmcatalog&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_nlmcatalog&amp;IdsFromResult=5181012" ref="log$=recordlinks">NLM Catalog</a><div class="brieflinkpop offscreen_noflow">Related NLM Catalog Entries</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/32859608" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis.</a><span class="source">[Ann Rheum Dis. 2020]</span><div class="brieflinkpop offscreen_noflow">Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Plein S, Erhayiem B, Fent G, Horton S, Dumitru RB, Andrews J, Greenwood JP, Emery P, Hensor EM, Baxter P, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ann Rheum Dis. 2020 Nov; 79(11):1414-1422. Epub 2020 Aug 28.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25381560" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial.</a><span class="source">[Trials. 2014]</span><div class="brieflinkpop offscreen_noflow">Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Erhayiem B, Pavitt S, Baxter P, Andrews J, Greenwood JP, Buch MH, Plein S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Trials. 2014 Nov 8; 15:436. Epub 2014 Nov 8.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29900829" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT.</a><span class="source">[Health Technol Assess. 2018]</span><div class="brieflinkpop offscreen_noflow">Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brown S, Everett CC, Naraghi K, Davies C, Dawkins B, Hulme C, McCabe C, Pavitt S, Emery P, Sharples L, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Health Technol Assess. 2018 Jun; 22(34):1-280. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/34406722" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Intensive therapy for moderate established rheumatoid arthritis: the TITRATE research programme</a><span class="source">[ 2021]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Intensive therapy for moderate established rheumatoid arthritis: the TITRATE research programme<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Scott DL, Ibrahim F, Hill H, Tom B, Prothero L, Baggott RR, Bosworth A, Galloway JB, Georgopoulou S, Martin N, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">2021 Aug</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31869016" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Identifying and treating high blood pressure in men under 55 years with grade 1 hypertension: the TREAT CASP study and RCT</a><span class="source">[ 2019]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Identifying and treating high blood pressure in men under 55 years with grade 1 hypertension: the TREAT CASP study and RCT<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Williams B, McFarlane E, Jedrzejewski D, Lacy PS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">2019 Dec</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=33780206" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=33780206" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=67d7a88067c23b31e0caa5d0">Using cardiovascular magnetic resonance to define mechanisms of comorbidity and ...</a><div class="ralinkpop offscreen_noflow">Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=2" href="/portal/utils/pageresolver.fcgi?recordid=67d7a87f67c23b31e0caa336">New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study</a><div class="ralinkpop offscreen_noflow">New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="/portal/utils/pageresolver.fcgi?recordid=67d7a87f67c23b31e0ca9bbc">Selenium supplementation to improve bone health in postmenopausal women: the SeM...</a><div class="ralinkpop offscreen_noflow">Selenium supplementation to improve bone health in postmenopausal women: the SeMS three-arm RCT<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=4" href="/portal/utils/pageresolver.fcgi?recordid=67d7a87e2f30673f7b18a28c">Probiotics to reduce antibiotic administration in care home residents aged 65 ye...</a><div class="ralinkpop offscreen_noflow">Probiotics to reduce antibiotic administration in care home residents aged 65 years and older: the PRINCESS RCT<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="/portal/utils/pageresolver.fcgi?recordid=67d7a87d2f30673f7b189ce4">Emergent aneurysm treatment compared with treatment on neurological improvement ...</a><div class="ralinkpop offscreen_noflow">Emergent aneurysm treatment compared with treatment on neurological improvement in patients with ruptured poor-grade aneurysmal subarachnoid haemorrhage: the TOPSAT2 RCT<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
<!-- Custom content below discovery portlets -->
<div class="col7">
</div>
</div>
</div>
<!-- Custom content after all -->
<div class="col8">
</div>
<div class="col9">
</div>
<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
(function($){
$('.skiplink').each(function(i, item){
var href = $($(item).attr('href'));
href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
$(item).on('click', function(event){
event.preventDefault();
$.scrollTo(href, 0, {
onAfter: function(){
href.focus();
}
});
});
});
})(jQuery);
</script>
</div>
<div class="bottom">
<div id="NCBIFooter_dynamic">
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
<component id="Breadcrumbs" label="helpdesk"/>-->
</div>
<div class="footer" id="footer">
<section class="icon-section">
<div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
<div class="grid-container container">
<div class="icon-section_container">
<a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
<defs>
<style>
.cls-11 {
fill: #737373;
}
</style>
</defs>
<title>Twitter</title>
<path class="cls-11" d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
</path>
</svg></a>
<a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
<title>Facebook</title>
<path class="cls-11" d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
</path>
</svg></a>
<a class="footer-icon" id="footer_linkedin" href="https://www.linkedin.com/company/ncbinlm" aria-label="LinkedIn"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
<title>LinkedIn</title>
<path class="cls-11" d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
</path>
</svg></a>
<a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
<defs>
<style>
.cls-11,
.cls-12 {
fill: #737373;
}
.cls-11 {
fill-rule: evenodd;
}
</style>
</defs>
<title>GitHub</title>
<path class="cls-11" d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
</path>
<path class="cls-12" d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
</path>
<path class="cls-12" d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
</path>
<path class="cls-12" d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
<path class="cls-12" d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
</path>
<path class="cls-12" d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
</path>
<path class="cls-12" d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
</path>
<path class="cls-12" d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
</svg></a>
<a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
<svg xmlns="http://www.w3.org/2000/svg" id="Layer_1" data-name="Layer 1" viewBox="0 0 40 40">
<defs><style>.cls-1{fill:#737373;}</style></defs>
<title>NCBI Insights Blog</title>
<path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"></path>
</svg>
</a>
</div>
</div>
</section>
<section class="container-fluid bg-primary">
<div class="container pt-5">
<div class="row mt-3">
<div class="col-lg-3 col-12">
<p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
<ul class="list-inline social_media">
<li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter" target="_blank" rel="noopener noreferrer"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
<style type="text/css">
.st20 {
fill: #FFFFFF;
}
.st30 {
fill: none;
stroke: #FFFFFF;
stroke-width: 8;
stroke-miterlimit: 10;
}
</style>
<title>Twitter</title>
<g>
<g>
<g>
<path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7 c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116 c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3 c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6 C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
</g>
</g>
<circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
</g>
</svg></a></li>
<li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine" aria-label="Facebook" rel="noopener noreferrer" target="_blank">
<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
<style type="text/css">
.st10 {
fill: #FFFFFF;
}
.st110 {
fill: none;
stroke: #FFFFFF;
stroke-width: 8;
stroke-miterlimit: 10;
}
</style>
<title>Facebook</title>
<g>
<g>
<path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9 v67.5H135v-67.5h21.7L159,99.1z"></path>
</g>
</g>
<circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
</svg>
</a></li>
<li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube" target="_blank" rel="noopener noreferrer"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
<title>Youtube</title>
<style type="text/css">
.st4 {
fill: none;
stroke: #FFFFFF;
stroke-width: 8;
stroke-miterlimit: 10;
}
.st5 {
fill: #FFFFFF;
}
</style>
<circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
<g transform="translate(0,-952.36218)">
<path class="st5" d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7 v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
</g>
</svg></a></li>
</ul>
</div>
<div class="col-lg-3 col-12">
<p class="address_footer text-white">National Library of Medicine<br />
<a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323" class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br />
Bethesda, MD 20894</a></p>
</div>
<div class="col-lg-3 col-12 centered-lg">
<p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br />
<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="text-white">FOIA</a><br />
<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
</div>
<div class="col-lg-3 col-12 centered-lg">
<p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br />
<a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br />
<a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
</div>
</div>
<div class="row">
<div class="col-lg-12 centered-lg">
<nav class="bottom-links">
<ul class="mt-3">
<li>
<a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
</li>
<li>
<a class="text-white" href="https://www.nih.gov/">NIH</a>
</li>
<li>
<a class="text-white" href="https://www.hhs.gov/">HHS</a>
</li>
<li>
<a class="text-white" href="https://www.usa.gov/">USA.gov</a>
</li>
</ul>
</nav>
</div>
</div>
</div>
</section>
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>
<script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
</div>
</div>
<!--/.page-->
</div>
<!--/.wrap-->
</div><!-- /.twelve_col -->
</div>
<!-- /.grid -->
<span class="PAFAppResources"></span>
<!-- BESelector tab -->
<noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-toc&amp;ncbi_acc=NBK568919&amp;ncbi_domain=ukeme0804&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK568919/&amp;ncbi_pagename=Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study - NCBI Bookshelf&amp;ncbi_bookparttype=toc&amp;ncbi_app=bookshelf" /></noscript>
<!-- usually for JS scripts at page bottom -->
<!--<component id="PageFixtures" label="styles"></component>-->
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal104 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4209313/4212053/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>